Holen Sie sich die Stockscreener-App
2.46
0.00%
0.00
Handel nachbörslich:
2.41
-0.05
-2.03%
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
Institution Moves: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Insider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone - The Manila Times
Psyence Biomedical Ltd. Strengthens Pharmaceutical-Grade Manufacturing Capabilities Through Strategic Investment in PsyLabs - Quiver Quantitative
Inside Psyence BioMed’s debt-free push into $8.75B psychedelic drugs - Stock Titan
Aug Rallies: Is 1stdibsCom Inc stock a smart retirement pick2026 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn
Aug Highlights: Will Psyence Biomedical Ltd. Equity Warrant be affected by tariffs2026 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
Death Cross: Whats the beta of Psyence Biomedical Ltd stockPortfolio Growth Summary & High Win Rate Trade Tips - baoquankhu1.vn
Can Psyence Biomedical Ltd. stock withstand economic slowdownJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - Naître et grandir
Market Outlook: Will Psyence Biomedical Ltd Equity Warrant benefit from government policyTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
Aug PostEarnings: Will Psyence Biomedical Ltd outperform its industry peers2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
Gainers Report: Is Psyence Biomedical Ltd a top pick in the sector2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru
Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times
Natural psilocybin shipped to Australia for cancer palliative care trial - Stock Titan
Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks
Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan
VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn
Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru
PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI
Psyence Biomedical shares rise following equity investment agreement - MSN
Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq
Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada
Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn
Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru
Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN
Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI
Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks
Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment - The Spec
Psyence Biomedical Shareholders Approve Board, Auditor and Share Consolidation Authority - The Globe and Mail
PBM SEC FilingsPsyence Biomedical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
Does Psyence Biomedical Ltd. stock have upside surprise potential2025 Buyback Activity & Reliable Entry Point Trade Alerts - mfd.ru
Weiner discloses 51,850-share, 5.07% stake in Psyence Biomedical (PBM) - Stock Titan
Growth Review: Does Bitfarms Ltd align with a passive investing strategyTrade Performance Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
Will Psyence Biomedical Ltd. outperform its industry peersMarket Sentiment Report & Precise Trade Entry Recommendations - mfd.ru
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders - Bitget
Psyence Biomedical Ltd. Announces Shareholder Meeting Results, Directors Elected and Share Consolidation Authority Granted - Quiver Quantitative
Psilocybin developer’s investors back plan to combine shares up to 250-for-1 - Stock Titan
Sectors Review: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Weekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Oil Prices & AI Forecast for Swing Trade Picks - mfd.ru
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - The Globe and Mail
PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks
Psyence BioMed Enters Put Option Agreement with PsyLabs - Intellectia AI
Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - The Spec
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):